Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Oct 13:4:19.
doi: 10.1186/1477-9560-4-19.

Antithrombin significantly influences platelet adhesion onto immobilized fibrinogen in an in-vitro system simulating low flow

Affiliations

Antithrombin significantly influences platelet adhesion onto immobilized fibrinogen in an in-vitro system simulating low flow

Robert Loncar et al. Thromb J. .

Abstract

Background: Adhesion of platelets onto immobilized fibrinogen is of importance in initiation and development of thrombosis. According to a recent increase in evidence of a multiple biological property of antithrombin, we evaluated the influence of antithrombin on platelet adhesion onto immobilized fibrinogen using an in-vitro flow system.

Methods: Platelets in anticoagulated whole blood (29 healthy blood donors) were labelled with fluorescence dye and perfused through a rectangular flow chamber (shear rates of 13 s-1 to 1500 s-1). Platelet adhesion onto fibrinogen-coated slips was assessed using a fluorescence laser-scan microscope and compared to the plasma antithrombin activity. Additionally the effect of supraphysiological AT supplementation on platelets adhesion rate was evaluated.

Results: Within a first minute of perfusion, an inverse correlation between platelet adhesion and plasma antithrombin were observed at 13 s-1 and 50 s-1 (r = -0.48 and r = -0.7, p < 0.05, respectively). Significant differences in platelet adhesion related to low (92 +/- 3.3%) and high (117 +/- 4.1%) antithrombin activity (1786 +/- 516 U vs. 823 +/- 331 U, p < 0.05) at low flow rate (13 s-1, within first minute) have been found. An in-vitro supplementation of whole blood with antithrombin increased the antithrombin activity up to 280% and platelet adhesion rate reached about 65% related to the adhesion rate in a non-supplemented blood (1.25 +/- 0.17 vs. 1.95 +/- 0.4 p = 0.008, respectively).

Conclusion: It appears that antithrombin in a low flow system suppresses platelet adhesion onto immobilized fibrinogen independently from its antithrombin activity. A supraphysiological substitution of blood with antithrombin significantly reduces platelet adhesion rate. This inhibitory effect might be of clinical relevance.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Platelet adhesion onto immobilized fibrinogen under different shear rate conditions with regard to the perfusion time (n = 29). 13 s-1 and 50 s-1 mimic venous flow and 1500 s-1 arterial flow. Platelet adhesion between 15 sec and five min of perfusion increased five-fold at shear rate of 13 s-1 and 14-fold at arterial shear rate of 1500 s-1. Per each subject 3 flow experiments were conducted (13 s-1, 50 s-1 and 1500 s-1). Finally 87 perfusion experiments were conducted. At each time point of perfusion (15 sec, 1 min and 5 min) a stack of 5 images was collected and analyzed.
Figure 2
Figure 2
Microphotographs of platelets adhesion onto immobilized fibrinogen after 1 minutes (A) and 5 minutes (B) of perfusion at shear rate of 1500 s-1.
Figure 3
Figure 3
Plot of plasma antithrombin activity and platelet adhesion expressed as absolute fluorescence under low shear stress (n = 29, shear rate 13 s-1, 15 sec of perfusion). Spearman's rank correlation coefficient was -0.53, p < 0.05.
Figure 4
Figure 4
Platelet adhesion under different shear rates was selected according to the plasma antithromin activity of respected samples. Low activity = plasma AT activity <95% (n = 7) and high activity = plasma AT activity >105% (n = 13). Statistically significant difference in platelet adhesion with regard to the low and high AT activity was observed at 13 s-1 and 50 s-1 (p < 0.05). Similar trend was observed under arterial flow conditions but without statistical significance.
Figure 5
Figure 5
Anticoagulated blood (n = 8) was aliquoted and one aliquot was supplemented with AT (final activity 280%). Both aliquots were further perfused through rectangular flow chamber according to our experimental protocol. At low flow conditions (13 s-1) AT supplemented blood showed significantly lower platelet adhesion rate (65% of adhesion compared with non-supplemented blood, p < 0.05) between fifth and first minute.

References

    1. Stassen JM, Arnout J, Deckmyn H. The hemostatic system. Curr Med Chem. 2004;11:2245–2260. - PubMed
    1. Rosenberg RD. Biochemistry of heparin antithrombin interaction and the physiological role of this natural anticoagulation mechanism. Am J Med. 1989;87:2S–9S. doi: 10.1016/0002-9343(89)80523-6. - DOI - PubMed
    1. Kremser L, Bruckner A, Heger A, Grunert T, Buchacher A, Josic D, Allmaier G, Rizzi A. Characterization of antithrombin III from human plasma by two-dimensional gel electrophoresis and capillary electrophoretic methods. Electrophoresis. 2003;24:4282–4290. doi: 10.1002/elps.200305651. - DOI - PubMed
    1. Larsson H, Akerud P, Nordling K, Raub-Segall E, Claesson-Welsh L, Bjork I. A novel anti-angiogenic form of antithrombin with retained proteinase binding ability and heparin affinity. J Biol Chem. 2001;276:11996–2002. doi: 10.1074/jbc.M010170200. - DOI - PubMed
    1. Lindahl U, Backstrom G, Thunberg L. The antithrombin-binding sequence in heparin. Identification of an essential 6-O-sulfate group. J Biol Chem. 1983;258:9826–9830. - PubMed

LinkOut - more resources